Literature DB >> 8690635

Hip stiffness following mixed conformal neutron and photon radiotherapy: a dose-volume relationship.

P J Chuba1, R Sharma, M Yudelev, M Duclos, F Shamsa, S Giacalone, C G Orton, R L Maughan, J D Forman.   

Abstract

PURPOSE: To determine the relationship between dose, volume, and the incidence of hip stiffness in patients who received conformal neutron irradiation for prostate cancer. METHODS AND MATERIALS: A series of dose-searching studies using neutron irradiation for prostate cancer were performed to determine the optimal dose, fraction size, field size, technique, and proportions of photon and neutron dose. Neutron doses ranged from 9 to 20 Gy and photon doses ranged from 0 to 38 Gy. Data were analyzed by using a hip stiffness grading scale.
RESULTS: Hip stiffness was recorded on follow-up examination in 30% of patients (40 out of 132) treated with fast neutrons or mixtures of fast neutron and photon radiation for prostate cancer. Hip stiffness was categorized as none (Grade 0, 92 patients), mild (Grade 1, 24 patients), moderate (Grade 2, 10 patients), or severe (Grade 3, 6 patients). The incidence of hip stiffness differed significantly by dose and volume in the five dose levels studied (p < 0.001).
CONCLUSIONS: By using a mixture of conformal neutron and photon irradiation and limiting the total neutron dose to less than 13 Gy, hip stiffness toxicity could be reduced to acceptable levels.

Entities:  

Mesh:

Year:  1996        PMID: 8690635     DOI: 10.1016/0360-3016(96)00136-8

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  2 in total

1.  Hip-related toxicity after prostate radiotherapy: Treatment related or coincidental?

Authors:  Michael J Zelefsky; Marisa A Kollmeier; Elan Gorshein; Xin Pei; Marina Torres; Sean McBride; Laura Happersett; Gil'ad N Cohen; Yoshiya Yamada
Journal:  Radiother Oncol       Date:  2016-10-15       Impact factor: 6.280

2.  Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.

Authors:  Patricia Mae G Santos; Andrew R Barsky; Wei-Ting Hwang; Curtiland Deville; Xingmei Wang; Stefan Both; Justin E Bekelman; John P Christodouleas; Neha Vapiwala
Journal:  Cancer       Date:  2019-09-10       Impact factor: 6.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.